Opportunity Information: Apply for PAR 17 340
The Collaborative Program Grant for Multidisciplinary Teams (RM1) is a National Institutes of Health (NIH) funding opportunity from the National Institute of General Medical Sciences (NIGMS) intended to back highly integrated, tightly coordinated research teams. The core idea is to fund projects that are genuinely team-science driven: each application must be built around a group of three to six Program Director(s)/Principal Investigator(s) (PDs/PIs) working together on a single, ambitious scientific problem that matters to the NIGMS mission. The program is aimed at big, difficult questions that are not realistically solvable by one lab, or even by a loosely connected set of labs. Reviewers are looking for strong evidence that the project needs deep scientific and managerial integration, where the outcomes depend on synergy, shared strategy, and deliberate coordination rather than parallel, independent work packages.
A key expectation is that the team will pursue far-reaching objectives capable of producing major advances in their field. In practical terms, that means the proposal should articulate a compelling overarching vision, explain why the problem is both important and hard, and show how combining distinct expertise across the PD/PI group creates capabilities that no single investigator could assemble alone. The FOA emphasizes “managed team interactions,” which signals that successful applications typically need a credible plan for leadership, decision-making, communication, conflict resolution, and coordination of milestones across the team. The project should read like one coherent program with interdependent aims, not a bundle of separate subprojects that could just as easily be funded as individual grants.
At the same time, the FOA draws clear boundaries around what it does not want to support. Applications that are primarily about building, expanding, or maintaining community resources are considered out of scope. Likewise, proposals centered mainly on creating new technologies, constructing infrastructure, or general platform development are not appropriate for this program. Those activities can be valuable, but under this announcement they cannot be the main thrust. The emphasis is on answering a major biological or biomedical research question through an integrated, multidisciplinary approach, rather than delivering a tool, database, resource center, or facility as the primary output.
Eligibility is broad and includes many common U.S. applicant organization types, such as public and private institutions of higher education, nonprofits (including both 501(c)(3) and non-501(c)(3) organizations), for-profit organizations (other than small businesses), small businesses, and various levels of government (state, county, city/township, and special district governments), as well as independent school districts. It also includes Native American tribal governments (federally recognized) and tribal organizations (including those other than federally recognized tribal governments), along with public housing authorities/Indian housing authorities. The announcement explicitly highlights additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.
Foreign eligibility is limited in a specific way. Non-domestic (non-U.S.) entities (foreign institutions/organizations) are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, “foreign components” as defined by the NIH Grants Policy Statement are allowed, meaning a U.S.-based applicant may include certain foreign activities or collaborations if they meet NIH’s definition and requirements for a foreign component. In other words, the application must be led by an eligible U.S. applicant organization, but it can incorporate approved international elements when justified.
Administratively, this is a discretionary grant opportunity in the health funding category under CFDA 93.859. The opportunity number is PAR-17-340, created on September 22, 2017, with an original closing date listed as January 29, 2020. The excerpted source data does not specify an award ceiling or the expected number of awards, so those details would typically be confirmed in the full FOA text and any related NIH notices.
Overall, this RM1 program is best understood as support for high-risk/high-reward, mission-relevant team science where the structure of the project is inseparable from the structure of the team. The strongest fit is a proposal that can clearly demonstrate: (1) a major scientific challenge aligned with NIGMS priorities, (2) a three-to-six PD/PI team whose combined expertise is necessary (not just helpful), (3) tightly linked aims that require ongoing integration, and (4) a realistic management plan showing how the collaboration will operate as a unified program and deliver transformative advances rather than incremental progress or primarily resource/technology outputs.Apply for PAR 17 340
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Collaborative Program Grant for Multidisciplinary Teams (RM1)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.859.
- This funding opportunity was created on 2017-09-22.
- Applicants must submit their applications by 2020-01-29. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Phenotypic and Functional Studies on FOXO3 Human Longevity Variants to Inform Potential Therapeutic Target Identification Research (R01 Clinical Trial Optional)
Previous opportunity: Centers of Excellence for Training in Glycosciences (K12)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 17 340
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 17 340) also looked into and applied for these:
| Funding Opportunity |
|---|
| Development of Valid Reliable Markers of Aging-Related Biologic Mechanisms for Human Studies (U01) Apply for RFA AG 18 018 Funding Number: RFA AG 18 018 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| NIH SIREN Neurologic Clinical Trials (U01 Clinical Trial Required) Apply for PAR 18 304 Funding Number: PAR 18 304 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (SBIR) (R43/R44 - Clinical Trial Not Allowed) Apply for PAR 18 402 Funding Number: PAR 18 402 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (STTR) (R41/R42 - Clinical Trial Not Allowed) Apply for PAR 18 403 Funding Number: PAR 18 403 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Amplify Family Planning and Sexual and Reproductive Health Activity (AMPLIFY-FP)) Apply for RFI 624 18 000001 Funding Number: RFI 624 18 000001 Agency: West Africa USAID-Ghana Category: Health Funding Amount: $18,500,000 |
| National Institute of General Medical Sciences Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grant (T32) Apply for PAR 17 341 Funding Number: PAR 17 341 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Immuno-Oncology Translation Network (IOTN): Cellular Immunotherapy Data Resource (CIDR) (U24) Apply for RFA CA 17 048 Funding Number: RFA CA 17 048 Agency: National Institutes of Health Category: Health Funding Amount: $1,200,000 |
| HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) Apply for PAR 18 319 Funding Number: PAR 18 319 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| Immuno-Oncology Translation Network (IOTN): Data Management and Resource-Sharing Center (DMRC) (U24) Apply for RFA CA 17 047 Funding Number: RFA CA 17 047 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Fundamental Science Research on Mind and Body Approaches (R21 - Clinical Trial Optional) Apply for PA 18 322 Funding Number: PA 18 322 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Fundamental Science Research on Mind and Body Approaches (R01 - Clinical Trial Optional) Apply for PA 18 323 Funding Number: PA 18 323 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Announcement of Anticipated Availability of Funds for Support for Expectant and Parenting Teens, Women, Fathers, and Their Families Apply for AH SP1 18 001 Funding Number: AH SP1 18 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,000,000 |
| NHLBI Program Project Applications (P01 - Clinical Trials Optional) Apply for PAR 18 405 Funding Number: PAR 18 405 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maintaining Immunity After Immunization (U01 - Clinical Trial Optional) Apply for RFA AI 17 034 Funding Number: RFA AI 17 034 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R43/R44 Clinical Trial Not Allowed) Apply for PAR 18 329 Funding Number: PAR 18 329 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R41/R42 Clinical Trial Not Allowed) Apply for PAR 18 326 Funding Number: PAR 18 326 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Immunity in the Elderly (R01) Clinical Trial Optional Apply for RFA AI 17 037 Funding Number: RFA AI 17 037 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Enhancing Central Neural Control of Mobility in Aging (U01 Clinical Trial Optional) Apply for RFA AG 18 019 Funding Number: RFA AG 18 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) Apply for PAR 18 406 Funding Number: PAR 18 406 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Role of Peripheral Proteostasis on Brain Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 18 020 Funding Number: RFA AG 18 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 17 340", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
